Bidil and Blood glucose increased - a phase IV clinical study of FDA data

Summary:

Blood glucose increased is found among people who take Bidil, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Bidil and have Blood glucose increased. It is created by eHealthMe based on reports of 500 people who have side effects when taking Bidil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

500 people reported to have side effects when taking Bidil.
Among them, 9 people (1.8%) have Blood glucose increased.

What is Bidil?

Bidil has active ingredients of hydralazine hydrochloride; isosorbide dinitrate. eHealthMe is studying from 483 Bidil users for its effectiveness, alternative drugs and more.

What is Blood glucose increased?

Blood glucose increased is found to be associated with 3,290 drugs and 2,637 conditions by eHealthMe.

Number of Bidil and Blood glucose increased reports submitted per year:

Could Bidil cause Blood glucose increased?

Gender of people who have Blood glucose increased when taking Bidil *:

female: 55.56 %
male: 44.44 %

Age of people who have Blood glucose increased when taking Bidil *:

Common drugs people take besides Bidil *:

Common side effects people have besides Blood glucose increased *:

High Blood Pressure: 5 people, 55.56%
Cardiac Failure Congestive: 4 people, 44.44%
Nausea (feeling of having an urge to vomit): 3 people, 33.33%
Pleural Effusion (water on the lungs): 2 people, 22.22%
Nausea And Vomiting: 2 people, 22.22%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 2 people, 22.22%
Pain: 2 people, 22.22%
Hyperkalemia (damage to or disease of the kidney): 2 people, 22.22%
Oedema Peripheral (superficial swelling): 2 people, 22.22%
Nervousness: 2 people, 22.22%

Common conditions people have *:

Type 2 Diabetes: 2 people, 22.22%
Diabetes: 2 people, 22.22%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 1 person, 11.11%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 11.11%
Cardiomyopathy (weakening of the heart muscle): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Bidil and have Blood glucose increased?

Check whether Blood glucose increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Blood glucose increased and when was it recovered:

Blood glucose increased in Bidil

Expand to all the drugs that have ingredients of hydralazine hydrochloride; isosorbide dinitrate:

Blood glucose increased and drugs with ingredients of hydralazine hydrochloride; isosorbide dinitrate

Alternative drugs to, pros and cons of Bidil:

Bidil (483 reports)

Blood glucose increased treatments and more:

Blood glucose increased (201,483 reports)

COVID vaccines that are related to Blood glucose increased:

Common drugs associated with Blood glucose increased:

All the drugs that are associated with Blood glucose increased:

Blood glucose increased (3,290 drugs)

Common conditions associated with Blood glucose increased:

Type 2 diabetes: 46,453 reports
Diabetes: 27,458 reports
Type 1 diabetes: 11,164 reports
High blood pressure: 7,712 reports

All the conditions that are associated with Blood glucose increased:

Blood glucose increased (2,637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydralazine hydrochloride; isosorbide dinitrate (the active ingredients of Bidil) and Bidil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.